Open Access. Powered by Scholars. Published by Universities.®
History of Science, Technology, and Medicine
Articles 1 - 2 of 2
Full-Text Articles in History
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
OncoLog MD Anderson's Report to Physicians (All issues)
- Transport Oncophysics Could Guide Pancreatic Cancer Treatment: Pancreatic ductal adenocarcinomas respond poorly to standard treatments. Researchers at The University of Texas MD Anderson Cancer Center are applying the principles of physics to characterize the tumors, and these analyses could lead to individualized therapy.
- Nivolumab Shows Potential in Treating Squamous Cell Carcinoma of the Anal Canal: Currently, there are no standard therapy options for patients with treatment-refractory metastatic squamous cell carcinoma of the anal canal (SCCA), but early results of a multi-institutional clinical trial (No. NCI9673) led by researchers at The University of Texas MD Anderson Cancer Center show that the …
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
OncoLog MD Anderson's Report to Physicians (All issues)
- Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
- Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to …